Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2000
05/23/2000CA2171637C Substituted azaheterocyclecarboxylic acids
05/18/2000WO2000028035A1 CHEMOKINE β-7
05/18/2000WO2000028019A2 Antisense oligomer
05/18/2000WO2000028004A1 Virus vectors and methods of making and administering the same
05/18/2000WO2000028001A1 Modified exosomes and uses
05/18/2000WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000WO2000027822A2 Tricyclic pyrazole derivatives
05/18/2000WO2000027815A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
05/18/2000WO2000027805A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/18/2000WO2000027423A2 Methods and compositions for treating common cold symptoms
05/18/2000WO2000027414A2 Inhibition of the formation of vascular hyperpermeability
05/18/2000WO2000027392A1 Chromone enteric release formulation
05/18/2000WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000WO2000027373A1 Dry powder pharmaceutical formulation
05/18/2000WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
05/18/2000WO2000027363A1 Aerosols comprising nanoparticle drugs
05/18/2000WO2000027360A1 Treatment set containing lungsurfactant compositions
05/18/2000WO2000027359A1 An inhalation system
05/18/2000WO2000010544A3 A method for preventing the onset of asthma
05/18/2000WO2000009734A3 Methods and compositions for use in spliceosome mediated rna trans-splicing
05/18/2000WO2000009130A3 New pharmaceutical uses for nos inhibitors
05/18/2000CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine
05/18/2000CA2350771A1 Chemokine .beta.-7
05/18/2000CA2350235A1 Tricyclic pyrazole derivatives
05/18/2000CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000CA2349679A1 Modified exosomes and uses
05/18/2000CA2349445A1 Antisense oligomer
05/18/2000CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same
05/18/2000CA2347916A1 Inhibition of the formation of vascular hyperpermeability
05/17/2000EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae
05/17/2000EP1000930A2 Tachykinin antagonists
05/17/2000EP1000623A1 Use of epinastine as antitussivum
05/17/2000EP1000144A2 Lactoferrin receptor genes of moraxella
05/17/2000EP1000064A1 Compounds
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/17/2000EP1000044A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
05/17/2000EP1000040A1 Il-5 inhibiting 6-azauracil derivatives
05/17/2000EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000EP1000034A1 Substituted 6-alkylphenanthridines
05/17/2000EP1000031A1 Vitronectin receptor antagonist
05/17/2000EP1000017A1 Il-8 receptor antagonists
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0999836A1 A pharmaceutical composition active in reducing production of mcp-1 protein
05/17/2000EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
05/17/2000EP0553272B1 Synthetic lung surfactant
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1253560A Sulfonamides for treatment of endothelin-mediated disorders
05/17/2000CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
05/17/2000CN1253509A Method of delivering halotherapy
05/17/2000CN1253501A IL-8 receptor antagonists
05/17/2000CN1253014A Chinese-medicinal decoction for treating lung diseases
05/17/2000CN1253005A Medicine for treating allergic rhinitis
05/17/2000CN1052425C Process for preparing articles for acute bronchitis
05/17/2000CN1052421C Medicine for curing bronchitis of old people
05/17/2000CN1052401C Medicaments
05/16/2000US6063903 Ligands for EPH-like receptors
05/16/2000US6063810 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
05/16/2000US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
05/16/2000US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use
05/16/2000US6063789 Antiinflammatory agents
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/16/2000CA1340994C Treatment of conditions and disease
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
05/11/2000WO2000026224A2 Novel macrolide antibiotics
05/11/2000WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025810A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025766A2 Use of nk antagonist for treating gastric asthma
05/11/2000WO2000025752A1 Multiparticulate modified release composition
05/11/2000WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery
05/11/2000WO2000025723A2 Methods and compositions for the prevention of tolerance to medications
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000025612A1 Smoking products containing antioxidants
05/11/2000WO2000018381A8 Use of epinastine as antitussivum
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2653839A1 Multiparticulate modified release composition
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2349241A1 Smoking products containing antioxidants
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347650A1 Transmembrane 4 proteins
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 878